<p>Representative images of (A) phosphorylated PKC-α in control and DN mice at baseline and after 12 weeks treatment with saline or sulodexide are shown. Original magnification x1000. Image-based computer assisted analysis was performed to semi-quantify the amount of phosphorylated PKC-α in the (B) glomeruli and (C) tubulo-interstitium of control and DN mice. Results are expressed as mean+SD of data obtained from 6 mice per group. <sup>§§§</sup><i>P</i><0.001, compared to baseline for the same group, <sup>###</sup><i>P</i><0.001, DN baseline vs non-diabetic baseline, ***<i>P</i><0.001, DN mice vs non-diabetic mice for the same treatment, <sup>‡‡‡</sup><i>P</i><0.001, saline vs sulodexide treatment for the same time-point in DN mice.</p
<p>(A) Western blot analysis showing the effect of 5 mM D-glucose, 30 mM D-glucose and 30 mM mannito...
<p><b>A</b>. Immunohistochemical analysis showed increased phosphorylation of Smad2/3 in mice with d...
Despite optimal control of hyperglycaemia, hypertension, and dyslipidaemia, the number of patients w...
<p>Representative images of (A) phosphorylated ERK in control and DN mice at baseline and after 12 w...
<p>(A) Representative images of PAS stained renal specimens obtained from control and DN mice at bas...
<p>(A) Gene expression of TGF-β1 in control and DN mice treated with saline or sulodexide as determi...
<p>(A) Gene expression of collagen type III (Coll III) in control and DN mice treated with saline or...
<p>(A) Gene expression of perlecan core protein in control and DN mice treated with saline or sulode...
<p>(A) Gene expression of collagen type IV (Coll IV) in control and DN mice treated with saline or s...
OBJECTIVE: Sulodexide is a mixture of glycosaminoglycans that may reduce proteinuria in diabetic nep...
<p>(A) Gene expression of heparanase in control and DN mice treated with saline or sulodexide as det...
Sulodexide is a mixture of glycosaminoglycans that may reduce proteinuria in diabetic nephropathy (D...
<p>(A) Gene expression of fibronectin (FN) in control and DN mice treated with saline or sulodexide ...
<p>(A) Gene expression of collagen type I (Coll I) in control and DN mice treated with saline or sul...
<p>(A) Urine albumin-to-creatinine (ACR) ratio, (B) serum creatinine level and (C) serum urea level ...
<p>(A) Western blot analysis showing the effect of 5 mM D-glucose, 30 mM D-glucose and 30 mM mannito...
<p><b>A</b>. Immunohistochemical analysis showed increased phosphorylation of Smad2/3 in mice with d...
Despite optimal control of hyperglycaemia, hypertension, and dyslipidaemia, the number of patients w...
<p>Representative images of (A) phosphorylated ERK in control and DN mice at baseline and after 12 w...
<p>(A) Representative images of PAS stained renal specimens obtained from control and DN mice at bas...
<p>(A) Gene expression of TGF-β1 in control and DN mice treated with saline or sulodexide as determi...
<p>(A) Gene expression of collagen type III (Coll III) in control and DN mice treated with saline or...
<p>(A) Gene expression of perlecan core protein in control and DN mice treated with saline or sulode...
<p>(A) Gene expression of collagen type IV (Coll IV) in control and DN mice treated with saline or s...
OBJECTIVE: Sulodexide is a mixture of glycosaminoglycans that may reduce proteinuria in diabetic nep...
<p>(A) Gene expression of heparanase in control and DN mice treated with saline or sulodexide as det...
Sulodexide is a mixture of glycosaminoglycans that may reduce proteinuria in diabetic nephropathy (D...
<p>(A) Gene expression of fibronectin (FN) in control and DN mice treated with saline or sulodexide ...
<p>(A) Gene expression of collagen type I (Coll I) in control and DN mice treated with saline or sul...
<p>(A) Urine albumin-to-creatinine (ACR) ratio, (B) serum creatinine level and (C) serum urea level ...
<p>(A) Western blot analysis showing the effect of 5 mM D-glucose, 30 mM D-glucose and 30 mM mannito...
<p><b>A</b>. Immunohistochemical analysis showed increased phosphorylation of Smad2/3 in mice with d...
Despite optimal control of hyperglycaemia, hypertension, and dyslipidaemia, the number of patients w...